First survival outcomes and additional secondary analyses from PURE-01: Pembrolizumab (Pembro) before radical cystectomy (RC) in muscle-invasive urothelial bladder carcinoma (MIBC)
2019 ◽
Vol 18
(1)
◽
pp. e1517
A. Necchi
◽
M. Bandini
◽
A. Gallina
◽
M. Bianchi
◽
D. Raggi
◽
...